当前位置: 首页 > 期刊 > 《中国现代医生》 > 2016年第36期 > 正文
编号:13068615
RGS20基因在Luminal型乳腺癌的表达及临床病理特征相关性研究(5)
http://www.100md.com 2016年12月25日 《中国现代医生》2016年第36期
     [22] Dent R,Trudeau M,Pritchard KI,et al. Triple-negative breast cancer:Clinical features and patterns of recurrence[J]. Clinical Cancer Research An Official Journal of the American Association for Cancer Research,2007,13(15 Pt 1):4429-4434.

    [23] Depiereux E. Enhanced Meta-analysis Highlights Genes Involved in Metastasis from Several Microarray Datasets[J].Journal of Proteomics & Bioinformatics,2011,(2):36-43.

    [24] Girgert R,Hanf V,Emons G,et al. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells[J]. Journal of Pineal Research,2009,47(1):23-31.

    [25] Lai L,Yuan L,Cheng Q,et al. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines[J]. Breast Cancer Research and Treatment,2009,118(2):293-305.

    [26] Yang L,Lee MM,Leung MM,et al. Regulator of G protein signaling 20 enhances cancer cell aggregation,migration,invasion and adhesion[J]. Cellular Signalling,2016, 28(11):1663-1672.

    [27] Warner ET,Tamimi RM,Hughes ME,et al. Racial and Ethnic Differences in Breast Cancer Survival:Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors[J]. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology,2015,33(20):2254-2261.

    (收稿日期:2016-06-12) (李权 孙艺涵 蔡业丰)
上一页1 2 3 4 5